Kolexia
Amedro Pascal
Pédiatrie
Hôpital Haut-lévêque
Pessac, France
496 Activités
1.6 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Cardiopathies congénitales Cardiopathies Défaillance cardiaque Cardiomyopathies Dystrophies musculaires Myopathie de Duchenne Cardiomyopathie dilatée Hypertension artérielle Malformations

Industries

Abbvie
4 collaboration(s)
Dernière en 2021
Medtronic
2 collaboration(s)
Dernière en 2021
Bayer
1 collaboration(s)
Dernière en 2021
AstraZeneca
1 collaboration(s)
Dernière en 2021

Dernières activités

PreciPed: Genetics of Ventriculo-arterial Discordance: Towards a PRECIsion Medicine in PEDiatric Cardiology
Essai Clinique (CHU Nantes)   20 mars 2024
Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial.
European heart journal   02 mars 2024
Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy.
Journal of cachexia, sarcopenia and muscle   14 janvier 2024
Children With Cardiac Disease and Heat Exposure: Catastrophic Converging Consequences?
Pediatric exercise science   03 janvier 2024
VU3D: Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle: A Cross-sectional Observational Multicenter Prospective Study
Essai Clinique (CHU Montpellier)   24 octobre 2023
SAIN&NORMES: Reference Values of Aerobic Fitness in the Contemporary Paediatric Population: VO2max Z-scores
Essai Clinique (CHU Montpellier)   24 octobre 2023
Follow-Heart: Evolution of Cardiopulmonary Fitness in Children With Congenital Heart Disease : a Longitudinal Multi-center Study
Essai Clinique (CHU Montpellier)   24 octobre 2023
SOPHRO CARE: Impact of Sophrology on Exercise Capacity of Adolescents and Young Adults With Congenital Heart Disease : Multicenter Randomized Controlled Trial
Essai Clinique (CHU Montpellier)   02 octobre 2023
Effectiveness of simulation-based communication training for cardio pediatricians in announcing congenital heart disease diagnosis in children: A randomized controlled trial (SIMUL - CHD)
FCPC 2023   01 septembre 2023
Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
Stem cell research   25 août 2023